Clinical Differences and Outcomes of COVID-19 Associated Pulmonary Thromboembolism in Comparison with Non-COVID-19 Pulmonary ThromboembolismSantiago de Cossio, Carmen Díaz‐Pedroche, D. Paredes et al.|Journal of Clinical Medicine|2022Cited by 4
Multidisciplinary management in chronic myeloid leukemia improves cardiovascular risk measured by SCOREAlberto Blanco Sánchez, Rosa Ayala, Rodrigo Gil Manso et al.|Frontiers in Pharmacology|2023Cited by 2
Thrombocytopenia and autoimmune hemolytic anemia in antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid syndrome alliance for clinical trials and InternatiOnal networking (APS ACTION) clinical database and repository (“Registry”)Zeynep Belce Erton, Doruk Erkan, Nina Kello et al.|Lupus|2025Cited by 2
Impact of SARS-CoV-2 infection therapies on the risk of venous thromboembolism and cardiovascular events from the SEMI-COVID-19 RegistryCrhistian‐Mario Oblitas, Pedro Jesús Esteve Atiénzar, Pablo Demelo-Rodríguez et al.|Scientific Reports|2025Cited by 0